Evidence map›Paper›PMID 42265078›Full record

ArticleMicrosystems & nanoengineering2026

A microfluidic platform for whole-membrane integrity profiling in live neuronal cells.

Till Ryser, Ata Krichene, Nicolò Marchi, Felix Rodriguez Espinal, Anne-Laure Mahul-Mellier, Hilal A Lashuel, Carlotta Guiducci

Abstract read
In one paragraph

Article in Microsystems & nanoengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Till RyserLaboratory of Life Science Electronics, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Ata KricheneLaboratory of Life Science Electronics, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Nicolò MarchiLaboratory of Life Science Electronics, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Felix Rodriguez EspinalLaboratory of Life Science Electronics, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Anne-Laure Mahul-MellierLaboratory of Molecular and Chemical Biology of Neurodegeneration, EPFL, Lausanne, Switzerland.
Hilal A LashuelLaboratory of Molecular and Chemical Biology of Neurodegeneration, EPFL, Lausanne, Switzerland. halashuel@qf.org.qa.
Carlotta GuiducciLaboratory of Life Science Electronics, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland. carlotta.guiducci@epfl.ch.ORCID http://orcid.org/0000-0002-1745-7782

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 205321 179086
6 · The paper itself

Abstract

Structural and functional compromise of the cellular membrane is a central mechanism in the pathogenesis of numerous diseases, including neurodegenerative disorders such as Alzheimer's and Parkinson's disease. However, existing techniques for assessing membrane integrity often lack the ability to provide dynamic, whole-cell measurements and are limited to localized damage detection or population-level analysis. There is a growing need for methods capable of monitoring membrane integrity over time at the single-cell level and across the entire membrane surface. In this study, we present a microfluidic platform for real-time, label-free assessment of membrane integrity by analyzing dielectric properties. We apply this system to investigate how different aggregated forms of α-Synuclein (aSyn), a protein that plays a central role in the pathogenesis of Parkinson's disease and disrupts neuronal membranes. Our platform integrates electrokinetic microdevices with 3D microelectrodes and imaging, enabling continuous analysis of up to 30 live neuronal cells per hour in flow. By measuring electrorotation responses, we quantify changes in plasma membrane capacitance in response to monomeric, oligomeric, and fibrillar aSyn. This approach allows direct, time-resolved comparison of membrane-disruptive effects across different aSyn conformations with single-cell resolution and whole-membrane sensitivity.

Identifiers

PMID42265078
PMCPMC13249814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.